Today: 4 March 2026
Browse Category

Stock Market 24 October 2025

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies closed a $14.2 billion acquisition of Mr. Cooper Group on Oct. 1, the largest mortgage merger to date. RKT stock trades near $17, up about 80% year-to-date but below its early October high of $22.56. Shares have rallied 50% since the merger was announced in March, with short interest at 57%. Q3 earnings are due Oct. 30, with analysts expecting EPS of $0.04, down 50% year-over-year.
American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

American Airlines raised its 2025 profit outlook to $0.65–$0.95 EPS, up from a prior forecast of up to a $0.20 loss. Shares jumped 6% to $12.77 on Thursday. Third-quarter revenue hit a record $13.7 billion, while adjusted earnings showed a smaller-than-expected loss at -$0.17 per share. Premium cabin sales and cost controls offset flat overall revenue.
24 October 2025
Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Inhibrx’s ozekibart cut risk of progression or death by 52% in Phase 2 chondrosarcoma trial, doubling median progression-free survival to 5.52 months versus placebo. Shares of INBX jumped about 70% intraday and closed at $28.36 on Oct. 23, then surged another 75–80% after hours. Management plans a BLA filing in Q2 2026. Ozekibart also showed high response rates in colorectal and Ewing sarcoma cohorts.
Uranium Boom Propels Denison Mines (DNN) to New Highs as Analysts Weigh Rally

Denison Mines (DNN) Rides Uranium Boom as Wheeler River Advances – What’s Next?

Denison Mines shares more than doubled in 2025, reaching multi-year highs as uranium prices hit $80–$83 per pound. The company’s Wheeler River project secured key provincial permits and awaits a federal license by December. Denison restarted uranium production for the first time in 15 years and raised $345 million for growth. All five brokerages covering Denison rate the stock a “Buy” or “Outperform.”
Incredible Rally: Bitfarms (BITF) Stock Jumps 148% YTD Amid Crypto Boom & AI Pivot

Bitfarms (BITF) Stock Whipsaws as Bitcoin Hits Record High, $500M AI Pivot Fuels Rally – What’s Next?

Bitfarms shares traded near $4.10 on Oct. 24 after plunging 40% from a 52-week high of $6.20 reached Oct. 14, tracking sharp swings in Bitcoin prices. The company raised $588 million this month to fund a new HPC/AI campus in Pennsylvania and announced CFO Jeff Lucas will retire Oct. 27, replaced by Jonathan Mir. Bitfarms remains unprofitable, posting a $29 million Q2 loss on $78 million revenue.
Opendoor’s Wild 2025 Ride: Meme-Stock Surge, Crypto Pivot & Housing Hopes – What’s Next for OPEN?

Opendoor’s 1600% Meme-Stock Rally Meets Reality – New CEO, Crypto Hype & Housing Woes Collide

Opendoor shares surged from under $1 to over $10 in 2025, driven by retail hype, before settling near $7 in late October. The company named Kaz Nejatian as CEO and signaled plans for up to 85% layoffs. Q2 revenue rose 5% to $1.6 billion, but Q3 sales are forecast to fall by half. Most analysts rate the stock a “Sell,” with price targets far below current levels.
Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

D-Wave’s share price surged nearly 3,000% in the past year, peaking at $46.75 on Oct. 15 before dropping to $27.30 and rebounding to $31.06 after reports of possible U.S. government equity deals with quantum firms. The company announced a €10 million sale of its Advantage2 system in Europe and posted first-half 2025 revenue of $18 million against a Q2 GAAP loss of $167 million. Trading volumes remain extremely high.
Tesla and Nokia Stocks Soar on EV Deliveries and 5G Deal Frenzy – What’s Next for Investors?

Tesla and Nokia Stocks Soar on EV Deliveries and 5G Deal Frenzy – What’s Next for Investors?

Tesla posted record Q3 revenue of $28.1 billion and delivered about 497,000 vehicles as buyers rushed to secure expiring U.S. tax credits. Higher costs and lower carbon-credit income cut profits, with EPS at $0.50 versus $0.55 expected. Tesla shares fell around 4% after hours on Oct. 22. As of Oct. 23, TSLA closed at $449.
Rigetti’s Quantum Leap: Stock Jumps 5,000% and Then Grinds Back – Bubble or Breakthrough?

Rigetti’s Quantum Leap: Stock Jumps 5,000% and Then Grinds Back – Bubble or Breakthrough?

Rigetti Computing stock surged nearly 5,000% in 2025, peaking at $56 before dropping 25% in late October to close at $39.60 on Oct. 23. The rally followed a $5.8M Air Force contract, new product launches, and reports of possible U.S. government equity stakes. Despite a $17–18B market cap, Q2 revenue was $1.8M with a $39.7M net loss. Analyst targets remain far below current trading levels.
Ford Stock Surges After Q3 Beat – But $1B Supply Shock and EV Slump Linger

Ford Stock Surges After Q3 Beat – But $1B Supply Shock and EV Slump Linger

Ford shares traded near $12 on Oct. 23, 2025, up about 20–25% year-to-date despite a volatile October. Q3 revenue hit $50.5 billion, beating estimates, but Ford cut its 2025 EBIT outlook after a key supplier fire expected to cost up to $2 billion. The company issued 109 U.S. recalls this year and faces continued EV losses. U.S. truck and SUV sales rose 8.2% in Q3, supporting its 5–6% dividend yield.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 24.10.2025

Ripple rebranded Hidden Road as Ripple Prime after an acquisition, launching what it calls the first global prime broker for crypto and using RLUSD stablecoin as collateral. President Trump reportedly pardoned Binance founder CZ, drawing new regulatory scrutiny to the exchange. Baidu April 2026 options began trading, with notable activity at the $120 put and $130 call strikes. Equinix shares rose above their 200-day moving average, reaching $847.
24 October 2025
Target Shocks Workers: 1,000 HQ Jobs Cut Before Christmas – Retail Giant’s Woes Deepen

Target Shocks Workers: 1,000 HQ Jobs Cut Before Christmas – Retail Giant’s Woes Deepen

Target will cut about 1,000 corporate jobs and eliminate 800 open roles, affecting roughly 8% of its headquarters staff. The move follows three straight quarters of sales declines and consumer backlash over inventory and diversity issues. Target shares hovered near five-year lows at $94 on Oct. 23, while Walmart stock hit record highs. Employees were told to work remotely next week as the company finalizes layoffs.
24 October 2025
Integer Holdings (NYSE: ITGR) Stock Plunges 37% on Revised Forecast – Key Takeaways

Integer Holdings Stock Plunges on Weak Forecast – Analysts Weigh In

Integer shares plunged 32% on Oct 23, 2025, closing near $74 after a weak 2026 outlook and slower-than-expected adoption of new medical devices. The stock has dropped 43% year-to-date and now trades about 48% below its 52-week high. Q3 revenue and profit beat expectations, but management trimmed 2025 sales guidance and warned of flat growth next year. Trading volume spiked to over 11 million shares.
24 October 2025
Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont’s Wild Ride: Gold Boom Propels Stock to Record Highs, Then Earnings Jolt – What’s Next for NEM?

Newmont shares hit a 52-week high near $98.60 in mid-October 2025 as gold topped $4,300/oz, briefly pushing its market cap above $100 billion. The stock then fell about 8–9% after gold prices pulled back sharply, trading in the mid-$80s by Oct. 24. Newmont beat Q3 earnings estimates but warned of weaker Q4 cash flow, sending shares down further after hours. Analyst outlooks remain bullish but caution over short-term volatility persists.
Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Shares Skyrocket 350% on FDA-Approved Drug Launch – What’s Next?

Scienture (NASDAQ: SCNX) soared 355% to close near $2.60 on Oct. 23, 2025, after announcing the launch of Arbli, the first FDA-approved liquid losartan. Shares fell about 25% after hours and swung between $0.83 and $2.60 on Oct. 24. The company secured distribution deals covering over 100 million patients and converted all convertible debt to equity earlier in October. Analyst coverage remains sparse, with a consensus “Sell” rating.
24 October 2025
Intel Stock Soars After Q3 Surprise – AI Boom and $15B in Deals Fuel 90% Rally (Analysts Weigh In)

Intel Stock Soars After Q3 Surprise – AI Boom and $15B in Deals Fuel 90% Rally (Analysts Weigh In)

Intel reported Q3 2025 revenue of $13.7 billion and adjusted EPS of $0.23, swinging to a $4.1 billion profit and beating forecasts. Shares jumped nearly 9% pre-market Oct 24, trading near a two-year high. The U.S. government, NVIDIA, and SoftBank have invested billions, boosting cash reserves. Analysts remain cautious, with most price targets well below current levels.
Shock Rally: Porsche Stock Climbs on CEO Shakeup & EV Innovations – Can the Upswing Last? (Oct 24, 2025)

Shock Rally: Porsche Stock Climbs on CEO Shakeup & EV Innovations – Can the Upswing Last? (Oct 24, 2025)

Porsche AG’s preferred shares jumped over 4% on Oct 23, 2025, closing above €45 and rising to €47 the next day after news of CEO Oliver Blume’s exit and Michael Leiters’ appointment. The stock remains down about 25% year-to-date, following a profit warning in September that cut 2025 margin forecasts to 2%. Analyst sentiment is mixed, with targets ranging from €31 to €63.
Go toTop